Accelerating Asia’s Progress in RNA Therapeutics & Vaccines with Targeted Delivery, Improved Safety & Manufacturing Capability for Clinical & Commercial Readiness
2025 Attending Companies Include:
Welcome to the Inaugural RNA-Based Therapeutics & Vaccines Summit Asia
Uniting RNA Therapeutic & Vaccine Developers from Across Asia
Asia is booming in RNA innovation and partnerships towards commercial markets following key investments from the Korea Disease Control and Prevention Agency (KDCA) to fight future disease outbreaks and China’s race towards the first RNA-based cancer vaccine, rapidly gaining global attention.
In response to this momentum, the inaugural RNA-Based Therapeutics & Vaccines Summit Asia launches in South Korea to offer the most comprehensive industry dedicated platform to connect Asia’s thriving RNA biopharma community with groundbreaking mRNA, sa-RNA, circular RNA and siRNA modalities and strategic insights to fast-track pipelines into the clinical and beyond.
Showcasing the industry’s innovations and scientific progress in emerging health threats, personalized cancer vaccines and rare diseases, with brand new never-before-seen data, covering the end-to-end from discovery through to manufacturing and commercial success.
Join 80+ key RNA experts from South Korea, China, Japan, Singapore and beyond, for an unrivalled learning and networking opportunity to develop the next generation of efficacious and safe RNA medicines for patients faster.
World-Class Speaker Faculty Includes:
2025 Sponsors:
Other Events in the World RNA Series
